# V1 Empirics Check — openai/gpt-5.1-codex-mini (Variant A)

**Model:** openai/gpt-5.1-codex-mini
**Variant:** A
**Date:** 2026-03-17T00:52:49.655251

---

**Idea Fidelity**

The paper largely follows the original idea manifest: it investigates whether the staggered legalization of online sports betting increased suicide mortality using the CDC’s Early Model-Based Provisional Estimates, and it focuses on the same 2018–2021 window of state treatment variation. Two deviations are noteworthy. First, the analysis sample is constrained to 34 states (10 treated) because many small states lack non-missing CDC median estimates, whereas the manifest had envisaged 51 jurisdictions and 14 treated states. The paper should be explicit about how this attrition might affect identification, especially since the missing states are systematically small and include some treated units. Second, while the manifest had emphasized heterogeneity mechanisms (bankruptcy rates, NFL season amplification) and a placebo on transportation deaths, the paper discusses only the NFL interaction and does not present bankruptcy heterogeneity or the placebo tests, despite mentioning a placebo in the table caption without results. Apart from these omissions, the identification strategy and research question remain faithful to the manifest.

---

**Summary**

This paper exploits the staggered rollout of online/mobile sports betting across U.S. states between 2018 and 2021 to estimate the effect of legalization on weekly suicide death counts using CDC provisional data. Employing both TWFE and Callaway–Sant’Anna estimators, the author finds a precise null: legalization is associated with a small, statistically insignificant decline in suicide deaths, a result that survives a suite of robustness checks and randomization inference. The paper interprets the null as evidence that expanded gambling access, at least in the short run, does not translate into detectable increases in population-level suicide mortality.

---

**Essential Points**

1. **Selection into the analysis sample may threaten external and internal validity.** The manifest emphasized 51 jurisdictions, but the estimation sample is limited to 34 states with non-missing model-based suicide estimates, and several of the treated states (IA, NH, WV) are absent. The paper should clarify whether the excluded states differ systematically in baseline suicide patterns, gambling legalization timing, or other covariates, and it should assess whether the identifying variation persists once these differences are considered. Without this, it is difficult to know whether the null result reflects the true effect or a consequence of analyzing a non-representative subset of jurisdictions.

2. **Power and effect size calibration against the hypothesis are underdeveloped.** The paper interprets a precise null as evidence that legalization does not increase suicides, but it never states the minimum detectable effect or clarifies whether the dataset has sufficient power to detect even modest effects implied by clinical priors. Given an average of ~24 weekly deaths per state and only 10 treated states, the standard errors (≈0.33) imply that the study is powered to detect changes of several deaths per week, which may still be too large relative to a plausible causal effect. A formal power analysis or simulation based on plausible increases in problem gambling prevalence would help assess how informative the null is. Otherwise, the paper risks equating “no detectable change” with “no effect,” which the clinical literature suggests may be overly strong.

3. **Parallel trends and treatment dynamics need clearer substantiation.** Although the paper presents a Callaway–Sant’Anna event study table, month +1 post-treatment is statistically significant (the only post-treatment coefficient outside the confidence band), and some pre-treatment coefficients (e.g., months −8 and −5) show large point estimates (albeit imprecise). The paper should more carefully discuss whether these fluctuations are noise or signal, possibly by presenting graphical event studies with confidence bands and by checking whether the significant month +1 estimate persists in alternative specifications. At minimum, the narrative should acknowledge that the event study is not entirely flat and argue why month +1 should not undermine the parallel trends assumption.

If the authors cannot convincingly address these three concerns, the paper’s current form is too fragile for publication.

---

**Suggestions**

1. **Document sample attrition in detail.** Provide a table listing all states excluded due to missing suicide estimates, their characteristics (population size, pre-trend suicide levels), and whether they legalized online betting during the period. This will help readers assess whether the analytic sample is missing critical variation, particularly since the manifest mentioned 14 treated states but the analysis effectively uses only 10. If possible, reweight the sample or conduct a bounding exercise to illustrate how the inclusion of the omitted states might shift the estimates.

2. **Enhance the placebo and heterogeneity analyses mentioned in the manifest.** The manifest promised placebo outcomes (transportation deaths, cancer mortality) and heterogeneity tests (bankruptcy rate interactions, NFL season). Only the NFL interaction appears in the paper, and even that result is under-discussed. Carry out the promised placebo estimations with transportation and cancer deaths, report their coefficients, and interpret them. For heterogeneity, explicitly estimate interactions with pre-existing financial distress indicators (e.g., state bankruptcy/foreclosure rates) and with NFL seasonality, clarifying whether any detectable heterogeneity aligns with the hypothesized financial-aggravation or seasonal-intensity channels.

3. **Quantify the study’s statistical power and minimum detectable effects.** Use the observed variation in the data (e.g., within- and between-state variance in suicide counts) to compute the smallest effect size that could be ruled out with 80–90% power, given 10 treated states. Compare this minimum detectable effect to plausible magnitudes derived from clinical evidence (e.g., doubling problem gambling prevalence leading to X additional deaths per year). Presenting this calibration will allow readers to interpret the null meaningfully rather than assuming that an “insignificant” result implies no harm.

4. **Address potential measurement issues in the CDC provisional data.** Discuss how the Bayesian smoothing that produces median estimates might attenuate short-run effects and whether the estimates are subject to systematic revision. If feasible, replicate the main TWFE specification using finalized NVSS annual death counts (perhaps aggregated at the state-year level) as a robustness check, even if it sacrifices temporal precision. Such a comparison would reassure readers that the null is not driven by the peculiarities of provisional model outputs.

5. **Clarify the interpretation of the pre-COVID finding.** The significant negative effect in the NJ/PA/IN/WV pre-2020 sample is interesting but potentially driven by volatility in a few quarters. Present the event study or segmented time series for this subsample to show whether a single quarter or a consistent trend is responsible. If the result is highly sensitive to, say, NJ’s shorter post-treatment window, mention that in the text. Alternatively, replicate the pre-COVID specification excluding each of the four states to show whether the negative effect vanishes when any one is omitted.

6. **Consider richer time controls or state trends.** Although week fixed effects capture national shocks, the pandemic’s heterogeneous timing and other state-level happenings (e.g., opioid epidemics) may confound treatment effects. Estimating specifications with state-specific linear trends or, better yet, interacting treatment with state-year shocks (if available) could help show that the null is not due to omitted trends. Also, impute “placebo” treatments (e.g., assign treatment dates to never-treated states) to show that low-frequency noise does not produce spurious estimates.

7. **Discuss longer-term implications and possible lagged effects.** The paper rightly notes that problem gambling may take years to develop. Consider estimating distributed-lag specifications or at least acknowledging that the current window predominantly captures short- to medium-term effects. If additional treated states have activated after 2021, note how future research could extend the panel. This will frame the null as provisional rather than definitive.

8. **Expand the discussion of policy relevance.** The conclusion touches on policymaker debates but could benefit from a more nuanced treatment. For example, if legalization does not alter suicide mortality but is associated with measurable financial distress (per Hollenbeck 2025), what does that imply for where regulators should focus? Are there interventions (e.g., mandatory self-exclusion, deposit limits) that might preemptively mitigate potential harms even if mortality is unaffected? Providing such context would increase the paper’s appeal to policy-oriented readers.

In sum, the paper addresses an important question with high-frequency data and modern estimators, but it would benefit from deeper engagement with sample selection, power, and the interpretation of auxiliary results.
